CN105678075A - Blood cell morphological analysis internet-of-things detection and diagnosis method and platform - Google Patents
Blood cell morphological analysis internet-of-things detection and diagnosis method and platform Download PDFInfo
- Publication number
- CN105678075A CN105678075A CN201610007199.XA CN201610007199A CN105678075A CN 105678075 A CN105678075 A CN 105678075A CN 201610007199 A CN201610007199 A CN 201610007199A CN 105678075 A CN105678075 A CN 105678075A
- Authority
- CN
- China
- Prior art keywords
- blood
- image
- user
- identification information
- morphological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000601 blood cell Anatomy 0.000 title claims abstract description 76
- 238000004458 analytical method Methods 0.000 title claims abstract description 65
- 238000001514 detection method Methods 0.000 title claims abstract description 63
- 230000000877 morphologic effect Effects 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000003745 diagnosis Methods 0.000 title claims abstract description 22
- 210000004369 blood Anatomy 0.000 claims abstract description 201
- 239000008280 blood Substances 0.000 claims abstract description 201
- 230000003213 activating effect Effects 0.000 claims abstract description 29
- 238000012545 processing Methods 0.000 claims abstract description 27
- 239000012491 analyte Substances 0.000 claims description 19
- 238000012360 testing method Methods 0.000 claims description 19
- 238000000338 in vitro Methods 0.000 claims description 7
- 238000013500 data storage Methods 0.000 claims description 6
- 238000007639 printing Methods 0.000 claims description 5
- 230000006855 networking Effects 0.000 claims description 3
- 230000001419 dependent effect Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 230000036541 health Effects 0.000 description 31
- 210000003743 erythrocyte Anatomy 0.000 description 10
- 238000010586 diagram Methods 0.000 description 7
- 238000007689 inspection Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000004445 quantitative analysis Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000007405 data analysis Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000004159 blood analysis Methods 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 108010004103 Chylomicrons Proteins 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000004430 acanthocyte Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses a blood cell morphological analysis internet-of-things detection and diagnosis method and a platform. The method includes the steps that firstly, an operation interface of a computer is displayed to a user, and input information or an operation instruction of the user is received; secondly, a hemogram detection device is connected, a blood image, transmitted by the hemogram detection device, of a current detected person can be displayed on the computer and a mobile terminal synchronously, and an activating blood morphological image and a dried blood morphological image of blood cells can be displayed respectively; thirdly, a save instruction of the user is received, the current blood image, the name of the hemogram and the hemogram are described, identification information of the detected person serves as relevance, and the activating blood morphological image and the dried blood morphological image of the blood cells serve as typical pictures; fourthly, an analysis instruction of the user is received, multiple typical pictures selected by the user are obtained, and a detection analysis report is formed; fifthly, operation instructions transmitted by remote clients including the mobile terminal are received, and corresponding data processing is executed according to the operation instructions.
Description
Technical Field
The invention belongs to the field of medical equipment and Internet of things, and particularly relates to a blood cell morphological analyte internet of things detection and diagnosis method and platform.
Background
Blood cell analysis is a technology for observing and analyzing red blood cells, white blood cells, blood components and the like through the test of a special instrument, and is one of the common means for clinical test in modern medicine. Because of different health states of human bodies, substances in blood and blood cell forms can be changed, but the existing blood cell analysis process is isolated and one-sided, focuses on counting detection and analysis of blood cell type component quantity and the like, and lacks form detection and analysis of blood cell blood circulation state and dry blood state; the blood cell morphology detected by each patient in each blood sampling is difficult to store and compare and is combined with historical detection results and statistical standards to diagnose the disease condition, so that continuous, comprehensive and accurate detection and analysis of the blood phase condition of the patient are difficult to establish; this problem is even more pronounced when the patient is examined in different hospitals or medical facilities. This has affected the diagnosis and treatment of many chronic diseases, as well as the timely screening for sub-health, occult diseases. Blood cell analysis reports issued by hospitals or medical institutions are usually only detection data such as blood cell type component quantity and the like, but blood activating form and dry blood form images and analysis reports of blood cells are not visual, comprehensive and deep enough for physical examination of patients; and written analysis reports also greatly limit the delivery and sharing of test results. In addition, the existing blood cell analysis and reporting process is often long, and the patient cannot know the test result at the first time, and the remote expert cannot synchronously know the examination condition of the patient to perform remote analysis and diagnosis, which causes inconvenience.
Disclosure of Invention
The invention aims to provide a blood cell morphological analysis thing-network-linked detection and diagnosis method and platform based on the Internet of things and a mobile network, which are used for providing a blood cell morphological analysis thing-network-linked detection and analysis method which can respectively display, store and traceback blood according to blood cell activating blood morphology, dried blood morphology and preset standards and can remotely, movably and share the whole detection process, besides a traditional blood cell type component quantity equivalent analysis way.
The technical scheme adopted by the invention for solving the technical problems is as follows:
a blood cell morphological analyte in-vitro detection and diagnosis platform, comprising: blood looks thing allies oneself with detecting system and blood looks check out test set, wherein, blood looks thing allies oneself with detecting system includes: an operation interface unit, configured to receive input information or an operation instruction of a user, where the input information at least includes: respectively collecting and inputting the blood activating morphological image and the dry blood morphological image of the blood cell by the identification information of the person to be detected, the blood phase name and the blood phase description related to the blood image; the image acquisition and display unit is used for connecting the blood phase detection equipment, acquiring and displaying a blood image of a current person to be detected transmitted by the blood phase detection equipment, and respectively displaying a blood activating form image and a dry blood form image of blood cells; the data storage unit is used for receiving the storage instruction transmitted by the operation interface unit, taking the current blood image, the blood phase name and the blood phase description as well as the identification information of the person to be detected as correlation, respectively taking the blood activating form image and the dry blood form image of the blood cells as typical images, and synchronously storing the local computer and the cloud database; the data processing unit is used for receiving the analysis instruction transmitted by the operation interface unit, acquiring a plurality of typical pictures selected by a user from the data storage unit, processing data according to preset standards and strategies, respectively forming a blood cell activating form and dry blood form detection and analysis report, and synchronously uploading the blood cell activating form and the dry blood form detection and analysis report to a local computer and a cloud database; the data connection unit also comprises a remote client connection subunit, which is used for connecting the remote client through a wire or a wireless way and receiving an operation instruction transmitted from the remote client; and transmitting the operation instruction to the data processing unit, and the data processing unit executes corresponding operation according to the operation instruction and feeds back the operation instruction to the remote client.
Preferably, the operation interface unit further includes: the parameter setting subunit is used for setting blood image display or shooting parameters and transmitting the blood image display or shooting parameters to the image acquisition and display unit; wherein, the blood image display or shooting parameters at least comprise one or a combination of the following: image resolution, RGB parameters, saturation, whether color enhancement, whether monochrome mode, whether auto exposure mode, exposure value, gamma, contrast.
Preferably, the data connection unit further comprises: and the printer connection subunit is used for connecting a local or remote printer and printing the detection analysis report and/or the blood image.
Preferably, the operation instruction transmitted by the remote client is a data viewing instruction, and the data viewing instruction at least includes the identification information of the person to be detected or the associated user identification information; the data processing unit is further used for inquiring the database storage unit according to the identification information of the person to be detected or the identification information of the associated user, and transmitting the image or the report to be acquired to the remote client so that the person to be detected or a remote expert can view the image or the report at the remote client; the remote client is a mobile phone client or a remote computer.
Preferably, the operation interface unit further includes an account setting and switching subunit, configured to register and switch an account of the user, and receive login of the user.
A blood cell morphological analyte in-line diagnostic method comprising: step 1) displaying an operation interface to a user, and receiving input information or an operation instruction of the user, wherein the input at least comprises the following steps: identification information of a person to be detected, a blood phase name and a blood phase description related to the blood image, and a blood activating morphological image and a dry blood morphological image of blood cells are respectively collected and input; step 2) connecting a blood phase detection device, displaying a blood image of a current person to be detected transmitted by the blood phase detection device, and respectively displaying a blood activating form image and a dry blood form image of blood cells; step 3) receiving a storage instruction of a user, taking the current blood image together with the name of the blood phase and the description of the blood phase as a correlation, and respectively storing the blood activating morphological image and the dry blood morphological image of the blood cells as typical images; step 4) receiving an analysis instruction of a user, acquiring a plurality of typical pictures selected by the user, processing data according to a preset standard and strategy, and respectively forming a detection analysis report on a blood activating morphological image and a blood drying morphological image of blood cells; and receiving an operation instruction transmitted from the remote client, executing corresponding data processing according to the operation instruction, and feeding back the operation instruction to the remote client.
Further, the method preferably further comprises, before step 2): setting blood image display or shooting parameters; wherein, the blood image display or shooting parameters at least comprise one or a combination of the following: image resolution, RGB parameters, saturation, whether color enhancement, whether monochrome mode, whether auto exposure mode, exposure value, gamma, contrast.
Further, it is preferable that, after the step 4), the method further includes: connect an external local or remote printer and pass the above report or image to the printer.
Further, a preferred method is that the operation instruction transmitted by the remote client is a data viewing instruction, and the data viewing instruction at least includes the identification information of the above person to be detected or the identification information of the associated user; inquiring and transmitting an image or a report to be acquired to a remote client according to the identification information of the person to be detected or the identification information of the associated user, so that the person to be detected or a remote expert can view the image or the report at the remote client; the remote client is a mobile phone client or a remote computer.
Further, a preferred method is that, before step 1), a step of receiving a login of the user, or a step of registering or switching the user is further included.
After the scheme is adopted, the quantitative analysis of routine blood physical examination and the morphological analysis of blood cell detection can be combined, and blood images and analysis detection reports are quickly transmitted to a detector or a remote expert, so that the intuitiveness, convenience, normalization, systematicness, early warning performance and timeliness of the blood cell morphological analysis are improved, and the depth and the breadth of health physical examination and chronic disease screening are greatly enhanced.
Additional features and advantages of the invention will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The objectives and other advantages of the invention will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.
Drawings
The present invention will be described in detail below with reference to the accompanying drawings so that the above advantages of the present invention will be more apparent. Wherein,
FIG. 1 is a schematic diagram of an embodiment of the blood cell morphology analyte in-vitro diagnostic platform of the present invention;
FIG. 2 is a schematic structural diagram of a blood cell morphological analysis in-vitro diagnostic platform according to the present invention;
FIG. 3 is a schematic diagram of the analysis steps in the blood cell morphology analyte-coupled diagnosis method of the present invention;
FIG. 4 is a schematic diagram of the blood phase analysis step in the blood cell morphological analysis in the method for diagnosing an analyte in an internet of things according to the present invention;
FIG. 5 is a schematic diagram of the operation of the remote client in the blood cell morphological analysis thing-to-thing diagnostic method of the present invention;
fig. 6a, 6b, 6c, 6d, 6e, and 6f are schematic views of app interfaces of a remote client connected to the blood cell morphological analysis thing networking diagnosis platform according to the present invention;
FIG. 7a, FIG. 7b, FIG. 7c, and FIG. 7d are operation interfaces of the blood-related diagnostic system in the blood cell morphological analysis diagnosis platform according to the present invention; fig. 8 is a schematic diagram of an embodiment of parameter setting of a blood image in a blood-related diagnostic system in a blood cellular morphological analysis-related diagnostic platform according to the present invention.
Detailed Description
The following detailed description of the embodiments of the present invention will be provided with reference to the drawings and examples, so that how to apply the technical means to solve the technical problems and achieve the technical effects can be fully understood and implemented. It should be noted that, as long as there is no conflict, the embodiments and the features of the embodiments of the present invention may be combined with each other, and the technical solutions formed are within the scope of the present invention.
The first embodiment is as follows:
as shown in fig. 1 and 2, the present invention discloses a blood cell morphological analysis thing-linked diagnosis platform, comprising: the blood phase detection device 101 is a blood phase detection device 101, wherein the blood phase detection device 101 selects a common high power microscope 1011 and a camera 1012 connected with the high power microscope, and of course, the two can be combined into one. The blood Internet of things detection system specifically comprises: an operation interface unit 107, configured to receive input information or an operation instruction of a user, where the input information at least includes: the input subunit is used for inputting the identification information of the person to be detected, the blood phase name and the blood phase description related to the blood image, and respectively collecting and inputting the blood activating morphological image and the dry blood morphological image of the blood cells; the image acquisition and display unit 102 is used for connecting the blood phase detection equipment, acquiring and displaying a blood image of a current person to be detected transmitted by the blood phase detection equipment, and respectively displaying a blood activating morphological image and a dry blood morphological image of blood cells; the data storage unit 104 is used for receiving the storage instruction transmitted by the operation interface unit, associating the current blood image with the blood phase name and the blood phase description by using the identification information of the person to be detected, and respectively storing the blood activating form image and the dry blood form image of the blood cells as typical images; the data processing unit 103 is configured to receive the analysis instruction transmitted by the operation interface unit, acquire a plurality of typical pictures selected by the user from the data storage unit, perform data processing according to preset standards and strategies, form a detection analysis report on the blood activating morphological image and the blood drying morphological image of the blood cells, and perform subsequent printing or transmit the detection analysis report to a remote client.
That is, through the platform, the quantitative analysis of the conventional physical examination and the morphological analysis of the blood cell detection can be combined, the blood image and the analysis detection report can be quickly transmitted to a detector or a remote expert, the intuitiveness, the convenience, the normalization, the systematicness, the early warning performance and the timeliness of the blood cell morphological analysis are improved, and the depth of the health physical examination and the chronic disease screening are greatly enhanced.
Example two:
the first embodiment is further described in detail below, wherein, in order to ensure the blood image capturing effect, the operation interface unit further includes: the parameter setting subunit is used for setting blood image display or shooting parameters and transmitting the blood image display or shooting parameters to the image acquisition and display unit; wherein, the blood image display or shooting parameters at least comprise one or a combination of the following: the image resolution, RGB parameters, saturation, whether color enhancement, whether monochrome mode, whether automatic exposure mode, exposure value, gamma and contrast can be ensured by setting or inputting the parameters. In addition, in order to communicate with the user or the person to be detected, the present invention further provides a data connection unit 105, including: and the printer connection subunit is used for connecting a local or remote printer and printing the detection analysis report and/or the blood image. The remote client connecting subunit is used for connecting the remote client through a wire or a wireless way and receiving an operation instruction transmitted from the remote client; and transmitting the operation instruction to the data processing unit, and the data processing unit executes corresponding operation according to the operation instruction and feeds back the operation instruction to the remote client. For example, in one embodiment, the operation instruction transmitted by the remote client is a data viewing instruction, and the data viewing instruction at least includes the identification information of the above person to be detected or the identification information of the associated user; the data processing unit further queries the database storage unit according to the identification information of the person to be detected or the identification information of the associated user, and transmits the image or the report to be acquired to a remote client, and accordingly, the query unit is arranged to achieve the functions, wherein the remote client is a mobile phone client or a remote computer, so that the person to be detected or a remote expert can view the image or the report at the remote client, and accordingly, rapid analysis and viewing are achieved. In addition, the operation interface unit also comprises an account setting and switching subunit, which is used for registering and switching user accounts and receiving user login, namely, different users can use the same system through the design.
Example three:
corresponding to the above platform embodiment, the present invention also provides a blood cell morphological analyte internet of things diagnosis method, comprising: step 1) displaying an operation interface to a user, and receiving input information or an operation instruction of the user, wherein the input at least comprises the following steps: identification information of a person to be detected, a blood phase name and a blood phase description related to the blood image; step 2) connecting the blood phase detection equipment and displaying the blood image of the current person to be detected transmitted by the blood phase detection equipment; step 3) receiving a storage instruction of a user, and storing the current blood image, the name of the blood phase and the description of the blood phase as a typical picture by taking the identification information of the person to be detected as association; and 4) receiving an analysis instruction of the user, acquiring a plurality of typical pictures selected by the user, processing data according to a preset strategy and forming a detection analysis report. Further, the method preferably further comprises, before step 2): setting blood image display or shooting parameters; wherein, the blood image display or shooting parameters at least comprise one or a combination of the following: image resolution, RGB parameters, saturation, whether color enhancement, whether monochrome mode, whether auto exposure mode, exposure value, gamma, contrast. Further, it is preferable that, after the step 4), the method further includes: connect an external local or remote printer and pass the above report or image to the printer. Preferably, the method further comprises the following steps: and receiving an operation instruction transmitted from the remote client, executing corresponding data processing according to the operation instruction, and feeding back the operation instruction to the remote client. Further, a preferred method is that the operation instruction transmitted by the remote client is a data viewing instruction, and the data viewing instruction at least includes the identification information of the above person to be detected or the identification information of the associated user; and inquiring and transmitting the image or report to be acquired to a remote client according to the identification information of the person to be detected or the associated user identification information. Further, a preferred method is that, before step 1), a step of receiving a login of the user, or a step of registering or switching the user is further included. Specifically, the method of the present invention has the same technical effects as those of the above device embodiments, that is, it can combine with the internet of things technology, combine the quantitative analysis of the conventional physical examination with the morphological analysis of the blood cell detection, and can quickly transmit the blood image and the analysis detection report to the examiner or the remote expert, etc., thereby improving the intuitiveness, convenience, timeliness, normalization, systematicness, early warning and shocking degree of the morphological analysis of the blood cell detection, and greatly enhancing the depth and breadth of the health physical examination. Example four: referring to FIGS. 3, 4 and 5, the method for diagnosing a blood cell morphology analyte in an analyte-linked manner according to the present invention specifically includes the following steps in detail, referring to FIG. 3: a blood collection step S100, collecting a test sample of a user; an observation and inspection step S200, wherein the acquired inspection sample is placed under a high-power microscope for amplification and observation, and a blood phase image displayed by the high-power microscope is uploaded to a database system by a camera; a data analysis processing step S300, which is to process the blood phase image received by the database system and execute the blood phase analysis step to obtain a blood phase inspection report; and a result output step S400, printing the blood phase test report and uploading the blood phase test report to the client of the user. In the blood sampling step, in order to improve the accuracy and comprehensiveness of the test result, the test sample comprises the live blood and the dry blood of the user. In the above observation and inspection step, the magnification of the high power microscope is not less than 2 ten thousand times when observing the live blood and not less than 6 thousand times when observing the dry blood. To improve the comprehensiveness of the test results, as shown in fig. 4, the blood phase analysis step preferably includes: analyzing whether red blood cells in the living blood are normal, analyzing whether white blood cells in the living blood are normal, analyzing whether platelets in the living blood are normal, and analyzing whether abnormalities such as cholesterol crystals and lipid plaques exist in the living blood; and analyzing whether the dry blood is normal.
Fig. 5 is a schematic diagram of the operation flow of the remote client. After the user logs in the blood phase system, if the user logs in for the first time, the user can be prompted to add an analyst, and blood phase parameters are set; then synchronizing the information of a room (which can be understood as a family) and members with the database system, and if the synchronization is not successful, prompting the user to register as a member; if the synchronization is successful, storing the blood phase image, generating a blood phase test report, and uploading the blood phase test report; and outputting a blood phase test result. The client system comprises one or more of a computer client, a mobile phone client, a mobile network terminal and an internet terminal. If so, the mobile phone client operates through the APP client, and a detection case is established through registration; transmitting case data to a blood data analysis and processing system by synchronous data transmission; the blood data analysis and processing system can carry out detection; the data analysis processing system synchronously transmits the blood detection result to an APP client; and an expert system is further arranged on the APP client side to feed back the diagnosis result in time. Further, in the above blood collection step, in order to improve the accuracy and comprehensiveness of the test result, the test sample includes live blood and dry blood of the user. For example, 1 drop of blood can be taken and 3 drops of dried blood can be taken as a test sample for testing. In the observation and inspection step, the magnification of the high power microscope is not less than 2 ten thousand times when the live blood is observed, and the magnification of the high power microscope is not less than 6 thousand times when the dry blood is observed, so that the inspection can be more accurately carried out, and a clear and visual blood phase image can be obtained. When the step of analyzing whether the red blood cells in the blood circulation are normal or not is executed, according to the common knowledge of the medical field, the normal red blood cells have the diameter of 7.2 microns, are concave, active, transparent, dispersed, strong in fluidity and good in deformability, and the blood plasma does not contain garbage impurities, otherwise, the normal red blood cells are analyzed to be abnormal red blood cells. For example, if the oval zone of pale excess red blood cells is greater than 10%, then iron deficiency anemia is indicated; if lemon-like red blood cells are observed, the digestion and absorption functions are poor; if the red blood cells are cracked and the fragments are much, such as helmet, triangle, mouth shape and flat shape, hemolytic anemia is suggested; if the acanthocyte is found, the poor function of the liver and spleen is indicated, such as drinking, taking treatment medicine recently, or the pathological changes of the liver such as heavy burden and fatty liver. When the step of analyzing whether platelets in the living blood are normal is performed, the aggregation of cells is mainly observed, and the aggregates form masses which can block blood vessels, affect blood circulation, and cause stroke and heart attack. 10-15 were mildly aggregated suggesting an effect on microcirculation; 15-25 were moderate, more than 25 were severe, suggesting premonitory stroke. Also observed were the releases: in the case of spicules, the liver is shown to be in a stressed state due to excessive fatigue, drug abuse, excessive alcohol consumption or reduced liver function due to fatty liver. If the needle is thick, large, or long, it indicates that the liver is heavily burdened, or fatty liver. If the structure is a network structure, it indicates cirrhosis or decreased liver function. When the step of analyzing whether there is a typical abnormality in the living blood is performed, the living blood is analyzed for the presence of an abnormal state of chylomicron, cholesterol crystal, lipid plaque, or enterotoxin. Example five: fig. 6a to fig. 6e are schematic views of app interfaces of a remote client connected to the blood cell morphology analyte internet of things diagnosis platform according to the present invention; FIG. 7a, FIG. 7b, FIG. 7c, and FIG. 7d are operation interfaces of the blood-related diagnostic system in the blood cell morphological analysis diagnosis platform according to the present invention; according to the interface, in the embodiment, a user or a person to be detected performs local query in a computer used for detection: inputting the name of a corresponding member in the name of the blood phase in a blood phase information management interface, and clicking a query button to query the blood phase pictures made by the member in different time periods; different time periods can be selected in the column of 'stage query', and the blood phase in the corresponding time period can be queried; in addition, it can also query, via the web: (1) a computer end: as long as the member has a user name and a password corresponding to the member in the health care management system, after logging in the health care management system, the member can see the originally stored blood phase picture in the personal blood examination album of the member, and can see the uploaded blood phase report in the blood phase examination. Thus, the member can conveniently consult and the doctor and the specialist can conveniently conduct remote consultation. (2) Internet client and cell-phone APP client: after the health treasure health management system is installed on the mobile phone, the mobile phone logs in the system, clicks the 'health' column, enters a 'my health' cabin, and respectively checks a blood phase picture and a blood phase report in a 'blood examination photo album' and a 'blood phase'. And through morphological analysis of morphological detection of red blood cells, blood activating slices and dry blood slices are detected, the blood activating slices and the dry blood slices are compared with normal blood cell morphology, the judged result is directly uploaded to a database for diagnosis, and the judgment result is fed back to a client in time for interactive data communication. Under the state of combining the Internet of things and the Internet, the diagnosis result is easily sent to each participant of the case member, diagnosis and treatment suggestion processing are quickly and timely carried out, and the patient does not need to go to a hospital for registration to wait for a long time for seeing a doctor. In addition, through the design of the associated user identification information, not only individual members but also family members can participate simultaneously, and particularly, the case member with family medical history has an important prompting function. The blood cell morphological analysis internet of things diagnosis method and the platform provided by the invention can be applied to the future gold development period of the health medical care service industry, and particularly the combination of the internet of things of the internet mobile network and the cloud platform big data technology enables the traditional health medical care service to have a plurality of subversive changes which are called by people. In the past, physical examination items which need to be checked in a hospital or a physical examination center for three days are all completed in less than thirty minutes by performing the health medical care endowment Internet of things service platform service through the invention; the medical health-care system also comprises high-end physical examination items which are difficult to realize in ordinary hospitals, such as tumor screening, senile dementia screening, psychological emotion index determination and the like. The technical scheme of the invention has the following technical effects: 1. the invention is applied to a health medical care elderly-care Internet of things service platform, can also provide blood cell morphological analysis and detection which can be carried out only by a high-end hospital outpatient service, can combine quantitative analysis of conventional physical examination with morphological analysis of blood cell detection through the Internet of things technology, and compares the quantitative analysis with the morphological analysis of the blood cell detection to verify each other, thereby greatly enhancing the depth and breadth of the health physical examination and greatly improving the intuitiveness, convenience, systematicness, early warning performance and shock degree of the health physical examination. 2. The health medical care endowment internet of things service platform which can be established by the invention is different from a general physical examination center, an intelligent wearable device company, a health care and health club, a community hospital and the like, and the latter can only provide health medical care and endowment service of a certain link; the invention can provide the health medical service of full chain holographic thing networking moving from daily health monitoring, professional general physical examination, first-class health intervention, remote medical consultation and comprehensive health care. 3. The client can synchronously obtain a matched and dedicated intelligent family health medical care and old-age care system on a computer of the client by simply downloading a smart phone client, such as a mobile phone client which can be named as Jiankangbao 365, so that the health conditions of the client and family can be monitored, known and mastered at any time, and various timely and convenient remote health medical services can be received. 4. The system is connected with the experience sub-center of the Internet of things service platform of each place, is applied to each region, comprises foreign patient users and physical examination users, and performs corresponding examination in numerous community health centers, enterprises and public institutions, community organizations, health and health care clubs, home care service institutions, health investment institutions and social circle clubs. 5. The invention also has important practical application value, greatly relieves the problems of doctors and patients and has remarkable social and economic benefits.
It should be noted that for simplicity of description, the above method embodiments are described as a series of acts or combination of acts, but those skilled in the art will recognize that the present application is not limited by the order of acts described, as some steps may occur in other orders or concurrently depending on the application.
Further, those skilled in the art should also appreciate that while the embodiments described in this specification pertain to preferred embodiments, the acts involved and needs to be described in this specification are presented as a series of combinations of acts for simplicity of description, but those skilled in the art should appreciate that the present application is not limited by the order of acts described, as some steps may occur in other orders or concurrently depending on the application.
Further, those skilled in the art should also appreciate that the embodiments described in the specification are preferred embodiments and that the acts and modules referred to are not necessarily required in this application.
As will be appreciated by one skilled in the art, embodiments of the present application may be provided as a method, system, or computer program product. Accordingly, the present application may take the form of an entirely hardware embodiment, an entirely software embodiment or an embodiment combining software and hardware aspects.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (10)
1. A blood cell morphological analyte in-vitro detection and diagnosis platform, comprising: blood looks thing allies oneself with detecting system and blood looks check out test set, wherein, blood looks thing allies oneself with detecting system includes: an operation interface unit, configured to receive input information or an operation instruction of a user, where the input information at least includes: identification information of a person to be detected, a blood phase name and a blood phase description related to the blood image, and a blood activating morphological image and a dry blood morphological image of blood cells are respectively collected and input; the image acquisition and display unit is used for connecting the blood phase detection equipment, can synchronously acquire and display the blood image of the current detector transmitted by the blood phase detection equipment at the computer end and the mobile end, and can respectively acquire and display the blood activating morphological image and the dry blood morphological image of the blood cells; the data storage unit is used for receiving the storage instruction transmitted by the operation interface unit, taking the current blood image, the blood phase name and the blood phase description as well as the identification information of the person to be detected as correlation, respectively taking the blood activating form image and the dry blood form image of the blood cells as typical images, and synchronously storing the local computer and the cloud database; the data processing unit is used for receiving the analysis instruction transmitted by the operation interface unit, acquiring a plurality of selected blood phase typical pictures from the data storage unit, performing data processing according to preset standards and strategies, respectively forming a blood cell activating form and dry blood form detection and analysis report, and synchronously uploading the blood cell activating form and the dry blood form detection and analysis report to a local computer and a cloud database; the data connection unit also comprises a remote client connection subunit, which is used for connecting the remote client through a wire or a wireless way and receiving an operation instruction transmitted from the remote client; and transmitting the operation instruction to the data processing unit, and the data processing unit executes corresponding operation according to the operation instruction and feeds back the operation instruction to the remote client side including the mobile terminal.
2. The blood cell morphology analyte in-vitro diagnostic platform according to claim 1, wherein the operation interface unit further comprises: the parameter setting subunit is used for setting blood image display or shooting parameters and transmitting the blood image display or shooting parameters to the image acquisition and display unit; wherein, the blood image display or shooting parameters at least comprise one or a combination of the following: image resolution, RGB parameters, saturation, whether color enhancement, whether monochrome mode, whether auto exposure mode, exposure value, gamma, contrast.
3. The blood cell morphology analyte-linked diagnostic platform of claim 1 or 2, further comprising a data connection unit comprising: and the printer connection subunit is used for connecting a local or remote printer and printing the detection analysis report and/or the blood image.
4. The blood cell morphological analysis thing networking diagnostic platform of claim 1, wherein the operation instruction transmitted by the remote client is a data viewing instruction, and the data viewing instruction at least comprises the identification information of the person to be detected or the associated user identification information; the data processing unit is further used for inquiring the database storage unit according to the identification information of the person to be detected or the identification information of the associated user, and transmitting the image or the report to be acquired to the remote client so that the person to be detected or a remote expert can view the image or the report at the remote client; the remote client is a mobile phone client or a remote computer.
5. The platform of claim 1 or 2, further comprising an account setting and switching subunit configured to register and switch an account of the user and receive a login of the user.
6. A blood cell morphological analyte in-vitro detection diagnosis method comprises the following steps: step 1) displaying a computer-side operation interface to a user, and receiving input information or an operation instruction of the user, wherein the input at least comprises the following steps: identification information of a person to be detected, a blood phase name and a blood phase description related to the blood image, and a blood activating morphological image and a dry blood morphological image of blood cells are respectively collected and input; step 2) connecting a blood phase detection device, displaying a blood image of a current person to be detected transmitted by the blood phase detection device, and respectively displaying a blood activating form image and a dry blood form image of blood cells; step 3) receiving a storage instruction of a user, taking the current blood image, the name of the blood phase and the description of the blood phase, taking the identification information of the person to be detected as correlation, taking the blood activating form image and the dry blood form image of the blood cells as typical images respectively, and synchronously storing the local computer and the cloud database; step 4) receiving an analysis instruction of a user, acquiring a plurality of typical pictures selected by the user, processing data according to preset standards and strategies, respectively forming a blood activating form and a dry blood form detection analysis report of blood cells, and synchronously storing the blood activating form and the dry blood form detection analysis reports into a local computer and a cloud database; and 5) receiving an operation instruction transmitted from the remote client, executing corresponding data processing according to the operation instruction, and feeding back the operation instruction to the remote client for the remote expert and the family member users to check.
7. The method for diagnosing a blood cell morphology analyte by using the in-vitro detection method according to claim 6, further comprising, before the step 2): setting blood image display or shooting parameters; wherein, the blood image display or shooting parameters at least comprise one or a combination of the following: image resolution, RGB parameters, saturation, whether color enhancement, whether monochrome mode, whether auto exposure mode, exposure value, gamma, contrast.
8. The method for diagnosing a blood cell morphology analyte-linked according to claim 6 or 7, further comprising, after the step 4): connect an external local or remote printer and pass the above report or image to the printer.
9. The method for detecting and diagnosing the blood cell morphological analyte according to claim 8, wherein the operation instruction transmitted by the remote client is a data viewing instruction, and the data viewing instruction at least comprises the identification information of the person to be detected or the associated user identification information; inquiring and transmitting an image or a report to be acquired to a remote client according to the identification information of the person to be detected or the identification information of the associated user, so that the person to be detected or a remote expert can view the image or the report at the remote client; the remote client is a mobile phone client or a remote computer.
10. The method for diagnosing the analyte-dependent measurement of blood cell morphology according to claim 6, further comprising a step of receiving a login of a user, or a step of registering or switching the user, before the step 1).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610007199.XA CN105678075B (en) | 2016-01-06 | 2016-01-06 | Diagnostic method and platform are surveyed in a kind of blood cell shape analyte joint inspection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610007199.XA CN105678075B (en) | 2016-01-06 | 2016-01-06 | Diagnostic method and platform are surveyed in a kind of blood cell shape analyte joint inspection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105678075A true CN105678075A (en) | 2016-06-15 |
| CN105678075B CN105678075B (en) | 2019-01-04 |
Family
ID=56299116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610007199.XA Active CN105678075B (en) | 2016-01-06 | 2016-01-06 | Diagnostic method and platform are surveyed in a kind of blood cell shape analyte joint inspection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105678075B (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108693096A (en) * | 2017-12-13 | 2018-10-23 | 青岛汉朗智能医疗科技有限公司 | Red blood cell detection method and system |
| CN109124598A (en) * | 2017-06-16 | 2019-01-04 | 深圳大森智能科技有限公司 | Healthy all-in-one machine and its control method |
| CN110767307A (en) * | 2019-09-20 | 2020-02-07 | 杭州憶盛医疗科技有限公司 | Novel artificial intelligent automatic diagnosis method for cell morphology |
| CN110783002A (en) * | 2019-11-22 | 2020-02-11 | 浙江艾普拉斯电子科技有限公司 | Domestic blood sample test equipment and system |
| CN111091893A (en) * | 2019-10-31 | 2020-05-01 | 深圳兰丁医学检验实验室 | Cytology auxiliary diagnosis system based on artificial intelligence |
| CN112481346A (en) * | 2020-12-03 | 2021-03-12 | 中国人民解放军陆军军医大学第二附属医院 | Automatic early warning system and method for detecting abnormal cells in peripheral blood cell morphology |
| CN113053509A (en) * | 2021-02-25 | 2021-06-29 | 南京鼓楼医院 | Intelligent remote consultation system for blood cell detection |
| CN113109337A (en) * | 2021-02-24 | 2021-07-13 | 南京鼓楼医院 | Detection platform convenient to blood cell collection |
| CN113192621A (en) * | 2021-02-24 | 2021-07-30 | 南京鼓楼医院 | Intelligent artificial film reading system for blood cell detection |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101681455A (en) * | 2007-04-23 | 2010-03-24 | 三星电子株式会社 | Remote medical-diagnosis system and method |
| CN104182649A (en) * | 2014-09-10 | 2014-12-03 | 钟礼军 | Handheld mobile internet-of-things extracorporeal rapid detector and use method |
-
2016
- 2016-01-06 CN CN201610007199.XA patent/CN105678075B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101681455A (en) * | 2007-04-23 | 2010-03-24 | 三星电子株式会社 | Remote medical-diagnosis system and method |
| CN104182649A (en) * | 2014-09-10 | 2014-12-03 | 钟礼军 | Handheld mobile internet-of-things extracorporeal rapid detector and use method |
Non-Patent Citations (4)
| Title |
|---|
| 《中国医改发展报告》编撰委员会编: "《中国医改发展报告2009-2014》", 31 December 2015 * |
| 杨华: "智能手机图像传输技术 （ 微信平台 ） 在脑血管病远程会诊中的价值", 《神经外科2013年年会》 * |
| 覃西 等: "细胞流变在心脑血管病诊断中的应用", 《中国微循环》 * |
| 陈夏盛: "血细胞分析仪通用信号采集存储系统设计", 《万方学位论文》 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109124598A (en) * | 2017-06-16 | 2019-01-04 | 深圳大森智能科技有限公司 | Healthy all-in-one machine and its control method |
| CN108693096A (en) * | 2017-12-13 | 2018-10-23 | 青岛汉朗智能医疗科技有限公司 | Red blood cell detection method and system |
| CN110767307A (en) * | 2019-09-20 | 2020-02-07 | 杭州憶盛医疗科技有限公司 | Novel artificial intelligent automatic diagnosis method for cell morphology |
| CN111091893A (en) * | 2019-10-31 | 2020-05-01 | 深圳兰丁医学检验实验室 | Cytology auxiliary diagnosis system based on artificial intelligence |
| CN110783002A (en) * | 2019-11-22 | 2020-02-11 | 浙江艾普拉斯电子科技有限公司 | Domestic blood sample test equipment and system |
| CN112481346A (en) * | 2020-12-03 | 2021-03-12 | 中国人民解放军陆军军医大学第二附属医院 | Automatic early warning system and method for detecting abnormal cells in peripheral blood cell morphology |
| CN112481346B (en) * | 2020-12-03 | 2022-12-09 | 中国人民解放军陆军军医大学第二附属医院 | Automatic early warning system and method for detecting abnormal cells in peripheral blood cell morphology |
| CN113109337A (en) * | 2021-02-24 | 2021-07-13 | 南京鼓楼医院 | Detection platform convenient to blood cell collection |
| CN113192621A (en) * | 2021-02-24 | 2021-07-30 | 南京鼓楼医院 | Intelligent artificial film reading system for blood cell detection |
| CN113053509A (en) * | 2021-02-25 | 2021-06-29 | 南京鼓楼医院 | Intelligent remote consultation system for blood cell detection |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105678075B (en) | 2019-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105678075B (en) | Diagnostic method and platform are surveyed in a kind of blood cell shape analyte joint inspection | |
| US11257215B2 (en) | Systems and methods for collecting and transmitting assay results | |
| Dimauro et al. | A new method and a non-invasive device to estimate anemia based on digital images of the conjunctiva | |
| Zoppini et al. | Prevalence of cardiovascular autonomic neuropathy in a cohort of patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) | |
| Hersh et al. | A systematic review of the efficacy of telemedicine for making diagnostic and management decisions | |
| CN101596098B (en) | Potential disease information comprehensive analysis system of modern traditional Chinese medicine | |
| Schellini et al. | Prevalence of diabetes and diabetic retinopathy in a Brazilian population | |
| US8924226B2 (en) | Interactive testing system for analysing biological samples | |
| US20160253460A1 (en) | Diagnostic information display control device, method, and program | |
| Williams et al. | Telemedical diagnosis of retinopathy of prematurity: accuracy of expert versus non-expert graders | |
| KR20090024808A (en) | Assessing dementia and dementia-type disorders | |
| CN201993766U (en) | Portable remote life multi-parameter monitoring terminal and constructed remote monitoring system | |
| CN106169022A (en) | General practitioner is health management system arranged | |
| CN103268422A (en) | Multi-user multi-parameter wireless detection, diagnosis, service and monitoring system | |
| CN107480433A (en) | Blood transfusion closed-loop information management system with function of statistic analysis | |
| CN111276230A (en) | Cardiovascular and cerebrovascular disease integrated hierarchical management system and method | |
| CN104931680A (en) | Portable urine protein detection system and method based on mobile Internet | |
| Hsu et al. | Gender-and age-dependent tongue features in a community-based population | |
| CN105193418A (en) | Body silhouette and extremity inspection system | |
| CN110047566B (en) | Medical data display platform | |
| CN113593667A (en) | Community two-cancer screening health management method and system | |
| WO2013043204A1 (en) | Systems and methods for collecting and transmitting assay results | |
| Martins et al. | The relative risk of cardiovascular death among racial and ethnic minorities with metabolic syndrome: data from the NHANES-II mortality follow-up | |
| Maker et al. | Automated Retinal Imaging System (ARIS) compared with ETDRS protocol color stereoscopic retinal photography to assess level of diabetic retinopathy | |
| Luethi et al. | Telehematology: critical determinants for successful implementation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |